Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Continuous Spatial Sequences of Lichen Sclerosus, Penile Intraepithelial Neoplasia, and Invasive Carcinomas: A Study of 109 Cases.

Cañete-Portillo S, Sanchez DF, Fernández-Nestosa MJ, Piris A, Zarza P, Oneto S, Gonzalez Stark L, Lezcano C, Ayala G, Rodriguez I, Hoang MP, Mihm MC, Cubilla AL.

Int J Surg Pathol. 2019 Aug;27(5):477-482. doi: 10.1177/1066896918820960. Epub 2019 Jan 7.

PMID:
30614356
2.

Effect of traditional and modern culinary processing, bioaccessibility, biosafety and bioavailability of eritadenine, a hypocholesterolemic compound from edible mushrooms.

Morales D, Tabernero M, Largo C, Polo G, Piris AJ, Soler-Rivas C.

Food Funct. 2018 Dec 13;9(12):6360-6368. doi: 10.1039/c8fo01704b.

PMID:
30456394
3.

Toward Minimal Residual Disease-Directed Therapy in Melanoma.

Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M, Adriaens C, Radaelli E, Wolter P, Bechter O, Dummer R, Levesque M, Piris A, Frederick DT, Boland G, Flaherty KT, van den Oord J, Voet T, Aerts S, Lund AW, Marine JC.

Cell. 2018 Aug 9;174(4):843-855.e19. doi: 10.1016/j.cell.2018.06.025. Epub 2018 Jul 12.

4.

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.

Mooradian MJ, Reuben A, Prieto PA, Hazar-Rethinam M, Frederick DT, Nadres B, Piris A, Juneja V, Cooper ZA, Sharpe AH, Corcoran RB, Flaherty KT, Lawrence DP, Wargo JA, Sullivan RJ.

Oncoimmunology. 2018 Feb 1;7(5):e1423172. doi: 10.1080/2162402X.2017.1423172. eCollection 2018.

5.

Lupus and scleroderma overlap features in a 28-year-old man with anti-PL-12 anti-synthetase syndrome.

Rana J, Moy AP, Piris A, Smith GP.

Dermatol Online J. 2017 Sep 15;23(9). pii: 13030/qt5vc6g7b6.

6.

Extraction of bioactive compounds against cardiovascular diseases from Lentinula edodes using a sequential extraction method.

Morales D, Piris AJ, Ruiz-Rodriguez A, Prodanov M, Soler-Rivas C.

Biotechnol Prog. 2018 May;34(3):746-755. doi: 10.1002/btpr.2616. Epub 2018 Feb 12.

PMID:
29388355
7.

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Cañadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA.

Cancer Discov. 2018 Feb;8(2):196-215. doi: 10.1158/2159-8290.CD-17-0833. Epub 2017 Nov 3.

8.

Lethal melanoma in children: a clinicopathological study of 12 cases.

Prieto-Granada CN, Lezcano C, Scolyer RA, Mihm MC Jr, Piris A.

Pathology. 2016 Dec;48(7):705-711. doi: 10.1016/j.pathol.2016.08.008. Epub 2016 Oct 27.

PMID:
27956274
9.

Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.

Shen CH, Kim SH, Trousil S, Frederick DT, Piris A, Yuan P, Cai L, Gu L, Li M, Lee JH, Mitra D, Fisher DE, Sullivan RJ, Flaherty KT, Zheng B.

Nat Med. 2016 Sep;22(9):1056-61. doi: 10.1038/nm.4155. Epub 2016 Aug 8.

10.

Clear Cell Carcinoma of the Penis: An HPV-related Variant of Squamous Cell Carcinoma: A Report of 3 Cases.

Sanchez DF, Rodriguez IM, Piris A, Cañete S, Lezcano C, Velazquez EF, Fernandez-Nestosa MJ, Mendez-Pena JE, Hoang MP, Cubilla AL.

Am J Surg Pathol. 2016 Jul;40(7):917-22. doi: 10.1097/PAS.0000000000000607.

PMID:
26848799
11.

Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.

Friedman AA, Amzallag A, Pruteanu-Malinici I, Baniya S, Cooper ZA, Piris A, Hargreaves L, Igras V, Frederick DT, Lawrence DP, Haber DA, Flaherty KT, Wargo JA, Ramaswamy S, Benes CH, Fisher DE.

PLoS One. 2015 Oct 13;10(10):e0140310. doi: 10.1371/journal.pone.0140310. eCollection 2015.

12.

Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.

Mochel MC, Hammond MR, Frederick DT, Alora-Palli MB, Piris A, Flaherty KT, Hoang MP.

J Am Acad Dermatol. 2015 Sep;73(3):491-9.e2. doi: 10.1016/j.jaad.2015.06.006. Epub 2015 Jul 16.

PMID:
26190239
13.

Use of Photodynamic Therapy and Sterile Water to Target Adipose Tissue.

Wanner M, Mihm MC Jr, Farinelli WA, Doukas A, Zurakowski D, Piris A, Avram MM, Klein JA, Anderson RR.

Dermatol Surg. 2015 Jul;41(7):803-11. doi: 10.1097/DSS.0000000000000385.

PMID:
26079592
14.

Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation.

Kim H, Frederick DT, Levesque MP, Cooper ZA, Feng Y, Krepler C, Brill L, Samuels Y, Hayward NK, Perlina A, Piris A, Zhang T, Halaban R, Herlyn MM, Brown KM, Wargo JA, Dummer R, Flaherty KT, Ronai ZA.

Cell Rep. 2015 Jun 9;11(9):1458-73. doi: 10.1016/j.celrep.2015.04.049. Epub 2015 May 28.

15.

Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations.

Mochel MC, Piris A, Nose V, Hoang MP.

Am J Clin Pathol. 2015 Jun;143(6):901-4. doi: 10.1309/AJCPG8LFJC0DHDQT.

PMID:
25972334
16.

BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.

Piris A, Mihm MC Jr, Hoang MP.

Hum Pathol. 2015 Feb;46(2):239-45. doi: 10.1016/j.humpath.2014.10.015. Epub 2014 Nov 4.

PMID:
25479927
17.

Primary mucosal melanoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of thirty-two cases.

Mochel MC, Duncan LM, Piris A, Kraft S.

Head Neck Pathol. 2015 Jun;9(2):236-43. doi: 10.1007/s12105-014-0570-4. Epub 2014 Oct 8.

18.

Multiple mantleomas: an unusual clinical presentation of an intriguing tumour.

Thielen AM, Blouin JL, Piris A, Mihm MC, Kaya G.

Br J Dermatol. 2014 Aug;171(2):417-8. doi: 10.1111/bjd.12924. Epub 2014 Aug 5. No abstract available. Erratum in: Br J Dermatol. 2014 Oct;171(4):920.

PMID:
25132573
19.

Extensive Squamous Cell Carcinoma of the Skin Related to Use of Sorafenib for Treatment of FLT3-Mutant Acute Myeloid Leukemia.

Fathi AT, Lin WM, Durazzo T, Piris A, Sadrzadeh H, Bernardo L, Borger DR, McAfee SL, Kroshinsky D, Chen YB.

J Clin Oncol. 2016 Mar 10;34(8):e70-2. doi: 10.1200/JCO.2013.50.7582. Epub 2014 Jul 14. No abstract available.

PMID:
25024084
20.

Rhabdomyosarcoma arising in a giant congenital melanocytic nevus.

Christman MP, Kerner JK, Cheng C, Piris A, Nepo AG, Sepehr A, Kroshinsky D.

Pediatr Dermatol. 2014 Sep-Oct;31(5):584-7. doi: 10.1111/pde.12359. Epub 2014 Jun 9.

PMID:
24913904
21.

Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade.

Cooper ZA, Juneja VR, Sage PT, Frederick DT, Piris A, Mitra D, Lo JA, Hodi FS, Freeman GJ, Bosenberg MW, McMahon M, Flaherty KT, Fisher DE, Sharpe AH, Wargo JA.

Cancer Immunol Res. 2014 Jul;2(7):643-54. doi: 10.1158/2326-6066.CIR-13-0215. Epub 2014 Apr 29.

22.

A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.

Konieczkowski DJ, Johannessen CM, Abudayyeh O, Kim JW, Cooper ZA, Piris A, Frederick DT, Barzily-Rokni M, Straussman R, Haq R, Fisher DE, Mesirov JP, Hahn WC, Flaherty KT, Wargo JA, Tamayo P, Garraway LA.

Cancer Discov. 2014 Jul;4(7):816-27. doi: 10.1158/2159-8290.CD-13-0424. Epub 2014 Apr 25.

23.

p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.

Lee JJ, Mochel MC, Piris A, Boussahmain C, Mahalingam M, Hoang MP.

Hum Pathol. 2014 May;45(5):1078-83. doi: 10.1016/j.humpath.2014.01.006. Epub 2014 Jan 28.

PMID:
24746214
24.

Cutaneous and mammary apocrine carcinomas have different immunoprofiles.

Piris A, Peng Y, Boussahmain C, Essary LR, Gudewicz TM, Hoang MP.

Hum Pathol. 2014 Feb;45(2):320-6. doi: 10.1016/j.humpath.2013.09.007. Epub 2013 Dec 14.

PMID:
24342430
25.

BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes.

Cooper ZA, Frederick DT, Juneja VR, Sullivan RJ, Lawrence DP, Piris A, Sharpe AH, Fisher DE, Flaherty KT, Wargo JA.

Oncoimmunology. 2013 Oct 1;2(10):e26615. Epub 2013 Oct 15.

26.

Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.

Simpson RM, Bastian BC, Michael HT, Webster JD, Prasad ML, Conway CM, Prieto VM, Gary JM, Goldschmidt MH, Esplin DG, Smedley RC, Piris A, Meuten DJ, Kiupel M, Lee CC, Ward JM, Dwyer JE, Davis BJ, Anver MR, Molinolo AA, Hoover SB, Rodriguez-Canales J, Hewitt SM.

Pigment Cell Melanoma Res. 2014 Jan;27(1):37-47. doi: 10.1111/pcmr.12185. Epub 2013 Nov 21.

27.

TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma.

Corcoran RB, Rothenberg SM, Hata AN, Faber AC, Piris A, Nazarian RM, Brown RD, Godfrey JT, Winokur D, Walsh J, Mino-Kenudson M, Maheswaran S, Settleman J, Wargo JA, Flaherty KT, Haber DA, Engelman JA.

Sci Transl Med. 2013 Jul 31;5(196):196ra98. doi: 10.1126/scitranslmed.3005753.

28.

Case records of the Massachusetts General Hospital. Case 21-2013. A 68-year-old man with metastatic melanoma.

Sullivan RJ, Lawrence DP, Wargo JA, Oh KS, Gonzalez RG, Piris A.

N Engl J Med. 2013 Jul 11;369(2):173-83. doi: 10.1056/NEJMcpc1302332. No abstract available.

PMID:
23841733
29.

Conjunctivitis, fever, and tender skin nodules.

Palioura S, Piris A, Chodosh J.

JAMA Ophthalmol. 2013 Jun;131(6):791, 792-3. doi: 10.1001/jamaophthalmol.2013.4495a. No abstract available.

PMID:
23764707
30.

Wolf isotopic response manifesting as postherpetic granuloma annulare: a case series.

Kapoor R, Piris A, Saavedra AP, Duncan LM, Nazarian RM.

Arch Pathol Lab Med. 2013 Feb;137(2):255-8. doi: 10.5858/arpa.2011-0643-OA.

PMID:
23368868
31.

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.

Frederick DT, Piris A, Cogdill AP, Cooper ZA, Lezcano C, Ferrone CR, Mitra D, Boni A, Newton LP, Liu C, Peng W, Sullivan RJ, Lawrence DP, Hodi FS, Overwijk WW, Lizée G, Murphy GF, Hwu P, Flaherty KT, Fisher DE, Wargo JA.

Clin Cancer Res. 2013 Mar 1;19(5):1225-31. doi: 10.1158/1078-0432.CCR-12-1630. Epub 2013 Jan 10.

32.

Melanoma staging: where are we now?

Piris A, Lobo AC, Duncan LM.

Dermatol Clin. 2012 Oct;30(4):581-92, v. doi: 10.1016/j.det.2012.06.001. Epub 2012 Jul 31. Review.

PMID:
23021047
33.

Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors.

Hung T, Piris A, Lobo A, Mihm MC Jr, Sober AJ, Tsao H, Tanabe KK, Duncan LM.

Hum Pathol. 2013 Jan;44(1):87-94. doi: 10.1016/j.humpath.2012.04.019. Epub 2012 Aug 30.

PMID:
22939951
34.

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.

Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H.

PLoS One. 2012;7(4):e35295. doi: 10.1371/journal.pone.0035295. Epub 2012 Apr 24.

35.

Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic.

Hawryluk EB, Sober AJ, Piris A, Nazarian RM, Hoang MP, Tsao H, Mihm MC Jr, Duncan LM.

J Am Acad Dermatol. 2012 Oct;67(4):727-35. doi: 10.1016/j.jaad.2012.02.036. Epub 2012 Apr 20.

PMID:
22521204
36.

EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.

Corcoran RB, Ebi H, Turke AB, Coffee EM, Nishino M, Cogdill AP, Brown RD, Della Pelle P, Dias-Santagata D, Hung KE, Flaherty KT, Piris A, Wargo JA, Settleman J, Mino-Kenudson M, Engelman JA.

Cancer Discov. 2012 Mar;2(3):227-35. doi: 10.1158/2159-8290.CD-11-0341. Epub 2012 Jan 16.

37.

Increased diagnosis of thin superficial spreading melanomas: A 20-year study.

Frangos JE, Duncan LM, Piris A, Nazarian RM, Mihm MC Jr, Hoang MP, Gleason B, Flotte TJ, Byers HR, Barnhill RL, Kimball AB.

J Am Acad Dermatol. 2012 Sep;67(3):387-94. doi: 10.1016/j.jaad.2011.10.026. Epub 2011 Dec 9.

PMID:
22153791
38.

RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.

Oberholzer PA, Kee D, Dziunycz P, Sucker A, Kamsukom N, Jones R, Roden C, Chalk CJ, Ardlie K, Palescandolo E, Piris A, MacConaill LE, Robert C, Hofbauer GF, McArthur GA, Schadendorf D, Garraway LA.

J Clin Oncol. 2012 Jan 20;30(3):316-21. doi: 10.1200/JCO.2011.36.7680. Epub 2011 Nov 7.

39.

Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases.

Chaux A, Pfannl R, Rodríguez IM, Barreto JE, Velazquez EF, Lezcano C, Piris A, Netto GJ, Cubilla AL.

Am J Surg Pathol. 2011 Apr;35(4):553-62. doi: 10.1097/PAS.0b013e3182113402.

PMID:
21399489
40.

AJCC melanoma staging update: impact on dermatopathology practice and patient management.

Piris A, Mihm MC Jr, Duncan LM.

J Cutan Pathol. 2011 May;38(5):394-400. doi: 10.1111/j.1600-0560.2011.01699.x. Epub 2011 Mar 9. Review.

PMID:
21385199
41.

Primary subcutaneous Alternaria alternata infection of the hand in an immunocompromised host.

Kpodzo DS, Calderwood MS, Ruchelsman DE, Abramson JS, Piris A, Winograd JM, Kotton CN.

Med Mycol. 2011 Jul;49(5):543-7. doi: 10.3109/13693786.2011.555848. Epub 2011 Feb 7.

PMID:
21299373
42.

Case records of the Massachusetts General Hospital. Case 35-2010. A 56-year-old man with cough, hypoxemia, and rash.

Kormos WA, Wu CC, Branda JA, Piris A.

N Engl J Med. 2010 Nov 18;363(21):2046-54. doi: 10.1056/NEJMcpc1003888. No abstract available.

PMID:
21083390
43.

Case records of the Massachusetts General Hospital. Case 30-2010. A 15-year-old boy with a recurrent skin lesion.

Tsao H, Tanabe KK, Lawrence DP, Piris A.

N Engl J Med. 2010 Sep 30;363(14):1352-60. doi: 10.1056/NEJMcpc1003889. No abstract available.

PMID:
20879885
44.

Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists.

Kolman O, Hoang MP, Piris A, Mihm MC Jr, Duncan LM.

J Am Acad Dermatol. 2010 Oct;63(4):661-7. doi: 10.1016/j.jaad.2009.09.047.

PMID:
20846568
45.

Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas.

Piris A, Scopsi L, Clemente C, Cetti Serbelloni F, Mihm MC Jr, Hoang MP.

Am J Dermatopathol. 2010 Aug;32(6):586-92. doi: 10.1097/DAD.0b013e3181cd64f2.

PMID:
20534988
46.

Global dermatopathology: Hansen's disease--current concepts and challenges.

Piris A, Lobo AZ, Moschella SL.

J Cutan Pathol. 2010 Apr;37 Suppl 1:125-36. doi: 10.1111/j.1600-0560.2010.01522.x. Review. No abstract available.

PMID:
20482684
47.

A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.

Clemente C, Bettio D, Venci A, Scopsi L, Rao S, Ferrari A, Piris A, Mihm MC Jr.

Pathologica. 2009 Oct;101(5):169-74.

PMID:
20218056
48.

Dynamic gene expression analysis links melanocyte growth arrest with nevogenesis.

Yang G, Thieu K, Tsai KY, Piris A, Udayakumar D, Njauw CN, Ramoni MF, Tsao H.

Cancer Res. 2009 Dec 1;69(23):9029-37. doi: 10.1158/0008-5472.CAN-09-0783. Epub 2009 Nov 10.

49.

Case records of the Massachusetts General Hospital. Case 22-2009. A 59-year-old man with skin and pulmonary lesions after chemotherapy for leukemia [corrected].

Patterson TF, Mackool BT, Gilman MD, Piris A.

N Engl J Med. 2009 Jul 16;361(3):287-96. doi: 10.1056/NEJMcpc0809065. No abstract available. Erratum in: N Engl J Med. 2009 Oct 1;361(14):1416.

PMID:
19605834
50.

Progress in melanoma histopathology and diagnosis.

Piris A, Mihm MC Jr.

Hematol Oncol Clin North Am. 2009 Jun;23(3):467-80, viii. doi: 10.1016/j.hoc.2009.03.012. Review.

PMID:
19464597

Supplemental Content

Support Center